Timothy Mills - Profile and Investment Details

Investor Profile

Timothy Mills is a Venture Capital, Private Equity Firm, Micro VC, Investor based in San Mateo, California, United States with a diverse investment portfolio that includes companies such as Chimerix, Glycomine Inc., Taligen Therapeutics, Axis Spine, CalciMedica, SpecificiT Pharma, Genteric, NovoStent Corporation, Oxford Drug Design, Metavention, Inc., Naviscan, Sotera Wireless, Asteres, Aderis Pharmaceuticals, Sotera Wireless, Inc., Kadmus Pharmaceuticals, AlteerNivo, CyThera, CoMentis, Xytis, Form3, Tomophase, BioTelemetry Healthcare, formerly CardioNet/Mednet, Torax Medical, Inc., Zapaq, Autologyx, ViaCyte, CardioNet, PreciThera, Neurovalens, Ista Pharmaceuticals, Pulsar Vascular, Baxter International Inc., Endocyte, Cylene Pharmaceuticals, Stentor Inc, Metavention, Lineagen, VenueScanner, Kuano, Torax Medical, DalCor Pharmaceuticals, UCI Health, Dynavax Technologies, Neomend, Axikin Pharmaceuticals, TheraVida, Artielle ImmunoTherapeutics, Net32, InfraReDx, Glycomine, SnapDragon Monitoring, Micrima, Altor BioScience, Gemin X Pharmaceuticals, Trinity Biosystems, Actimis Pharmaceuticals, . Over time, Timothy Mills has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Timothy Mills is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wellness, Women Founded, Enterprise Software, Fundraising, Investment Management, Life Science, Portfolio Management, Information Technology (IT), Strategic Planning, Venture Fundraising, Finance, Biotechnology, Medical Devices, Innovation, Consumer Internet, Consulting, Digital Health, Medical, Information Technology, B2B, Media and Entertainment, Healthcare Technology may find it worthwhile to explore potential connections with Timothy Mills, as their portfolio suggests a familiarity and interest in this area.

Understanding Timothy Mills’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.